Smith & Nephew
SNN | NYSE
$27.73
+$0.17 (+0.62%)
Sep 21, 2026, 1:20 PM ET · Market open
Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Key Executives
| Name | Position |
|---|---|
| Deepak S. Nath | Chief Executive Officer & Director |
| John Terence Rogers | Chief Financial Officer |
| Ajay Dhankhar | Chief Corporate Development & Strategy Officer |
| Alison Parkes | Chief Compliance Officer & Compliance APAC |
| Charles Reynolds | Head of Corporate Communication |
| Elga Lohler | Chief Human Resources Officer |
| Emily Heaven | Head of Investor Relations |
| Helen Barraclough | Group General Counsel & Company Secretary |
| Paul Connolly | President of Global Operations |
| Steve Kane | Head of Human Resources for the US, Global Marketing and Global R&D |
| Vasant Padmanabhan | President Research & Development, ENT and Emerging Markets |
Smith & Nephew
| Country | United Kingdom |
| IPO Date | Nov 15, 1999 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 18,362 |
| CEO | Deepak S. Nath |
Contact Details
Building 5 Croxley Park Hatters Lane Watford,
HRT WD18 8YE United Kingdom
Stock Details
| Ticker Symbol | SNN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000845982 |
| CUSIP Number | 83175M205 |
| ISIN Number | US83175M2052 |
| SIC Code | 3842 |
Recent News
- 7 hours ago / globenewswire.comSmith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
- 5 days ago / accessnewswire.comSmith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds
- 5 days ago / accessnewswire.comSmith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds
- 6 days ago / gurufocus.comIs It Too Late to Buy Smith & Nephew PLC (SNN) After 3.3% Rally? GF Value Says Undervalued
- 1 month ago / zacks.comSNN Advances Surgical Robotics Through Imperial College Partnership
- 1 month ago / globenewswire.comSmith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
- 2 months ago / globenewswire.comSmith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week
- 2 months ago / seekingalpha.comSmith & Nephew plc (SNN) Q2 2026 Earnings Call Transcript
- 2 months ago / zacks.comSmith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
- 2 months ago / globenewswire.comNew German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
Add to Watchlist
Select watchlists to add or remove SNN